EROAD (NZSE:ERD) Is Down 31.9% After Guidance Cut and North American Impairments – What’s Changed
In a recent announcement, EROAD downgraded its fiscal 2026 revenue guidance, reported up to NZ$150 million in North…
NZ stocks end lower while Eroad tanks – Market close
Locally, market leader Fisher and Paykel Healthcare (FPH) dropped $1.02 or 2.8% to $35.45, on turnover worth $14.7…